NHP2 and plasma cell myeloma: A report of our group [35] using microarray assay found increased expression of NOP10, GAR1 and NHP2 in myeloma cell lines and patients with plasma cell disorders, showing significant overexpression from monoclonal gammopathy of undetermined significance (MGUS) to plasma cell leukemia, indicating their association with tumor progression.